Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Wouldn’t pay much attention to stuff like that on penny stocks. It’s the drivers - news, herd mentality, trends, charts like that on fairly illiquid pennies don’t mean much.
Looking pretty strong atm… one rns from the mgmt and they can soon dampen everyone’s optimism lol hopefully not but I wouldn’t be surprised, 12 years and completely useless is about the size of it.
Noticed this rising from the dip back to 2.2p on 3rd April 2024.
Would of been a great top up.
Steady rise to today's 3.6p 8 days on.
Up 7.46% today spread 5.7% 60% gain over the 8 days .
Share had fallen back to 1.7p by 20th March.
These guys not so sure what the tea leaves are saying at only 8%
https://www.barchart.com/stocks/quotes/TERN.LN/opinion
Overall Average:
8% SELL
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal.
You are misleading people as usual, nothing to do with Talking Medicine or Tern, no mention at all.
Prof David Clifton, puts forward the suggestion whose team at Oxford’s AI for Healthcare lab
Drug-gpt by TM
Will be used & is needed
as a standard , by every single GP in UK and is far superior that chat-gpt who he calls just a bot...
https://www.theguardian.com/science/2024/mar/31/druggpt-new-ai-tool-could-help-doctors-prescribe-medicine-in-england
Maybe so, but don’t you think he could very likely be correct?
Wyld Networks
@WyldNetworks
·
2h
We are excited to share our latest Wyld Connect and Wyld Fusion updates with the #LoRaWAN ecosystem in the marketplace at #LoRaWANLive Munich. We look forward to seeing you this June.
Register NOW to join us:
https://bit.ly/LoRaWANLive-Munich
AI magazine recommending Tern
X twitter
The Best AI
@TheBestAI_
Exploring Cutting-Edge Technology: Tern's Talking Medicines Kicks off 2024 Triumphan
Tech investors may want to turn their gaze towards the 'Internet of Things' investor, Tern, as it holds a promising 23.8% equity share in Talking Medicines. As of the first fiscal quarter of 2024, Talking Medicines has witnessed record-breaking revenue bookings and substantial advancements in its groundbreaking Drug-GPT platform.
Tern has 4 hungry dogs to feed, placing on the way as all this ramptastic nonsense signifies!
Always a danger when they release good news, they usually only release bad news and ignore the good stuff
There is no fundraise anytime soon
This sort of web page needed for various events like an IPO, are we heading down that road?
https://talkingmedicines.com/compliance-hub/
Probably the split second before you invested lol
Fingers crossed, they don’t raise into the rise, going off many years of previous performance, odds are slim.
LSI USA 2024 | The Adoption of Immersive VR to Drive Digital Surgery
$
Home
$
Events & Webinars
$
On Demand
$
LSI USA 2024 | The Adoption of Immersive VR to Drive Digital Surgery
ON DEMAND
LSI USA 2024 | The Adoption of Immersive VR to Drive Digital Surgery
Speaking at LSI USA, Richard Vincent shares how FundamentalVR is removing friction and shortening the learning curve for medical devices and procedures by developing immersive VR solutions that deliver Competency @ Scale.
“The key challenge with the move to digital surgery is really about the skills transfer… I’m talking about tenured surgeons, their teams, their nursing, their tech, who need to acquire new skills around the digital surgery space…And that’s where FundamentalVR comes in – we get into that space and virtualize it.”
Richard Vincent, CEO and Co-Founder of FundamentalVR
https://fundamentalsurgery.com/lsi-usa-2024-the-adoption-of-immersive-vr-to-drive-digital-surgery/
Sounds like TM is ready to attract more funds from other investors where TERN cannot participate other than reduce its % holdings!
I see toothless Tom Win is at it again. He’s a weasel.
No numbers given for this or any previous quarter.
No indication if revenue was above or below revenue growth projections made byTM.
No indication of gross margins.
Cant remember the last time i felt this confident about Terns potential
Blue day but no numbers will make any increase restrained but target was £3m, with them ahead of expectations, new target could well be alot higher, looks like TM are on fire, first RNS in a long time to get me looking forward to trading at 8am
Great news but would be good to see some numbers, o don’t think they were producing any revenue of note befire?
According to the recent presentation companies like TM are valued at up to x50 revenues then this impressive growth might yet make TM into the jewel of Tern's portfolio, If they are that far ahead then Tern's stake could be worth around £115m if that valuation is spot on
Exciting times again maybe
Talking Medicines reports record revenue bookings and strategic partnerships in Q1 2024
Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, is pleased to note that Talking Medicines Limited ("Talking Medicines"), a company in which Tern currently holds 23.8% of the equity, has announced an update on its Q1 2024 performance, extracts of which are set out below.
Extracts from the Talking Medicines announcement:
"Talking Medicines, a pioneering leader in healthcare intelligence leveraging advanced data science and artificial intelligence, is pleased to announce a strong start to 2024, marked by record revenue bookings and significant advancements in its innovative platform, Talking Medicines Drug-GPT.
In the first quarter of 2024, Talking Medicines achieved significant success with its Talking Medicines Drug-GPT platform, which aims to revolutionise access to intelligence on pharmaceutical medicine brands and disease areas. This innovative technology has garnered substantial interest from leading global healthcare advertising agencies, who recognise its potential to transform strategies for pharmaceutical clients.
Among Talking Medicines' clients are some of the world's most prominent healthcare advertising agency networks, reaffirming the platform's efficacy in providing key insights derived from aggregated patient and healthcare professional conversations. By tapping into previously unseen data, Talking Medicines empowers its clients to drive better strategies and make informed decisions in relation to the pharmaceutical landscape.
Furthermore, Talking Medicines has forged strategic partnerships with both open and closed data communities, solidifying its commitment to expanding access to crucial insights. Notable among these partnerships is the collaboration with data aggregator Socialgist, which enables Talking Medicines to tap into millions of public conversational sites, enriching the Talking Medicines Drug-GPT platform with a wealth of diverse data sources.
Speaking on these achievements, Jo Halliday CEO expressed excitement about the company's trajectory and the transformative impact of Talking Medicines Drug-GPT on the healthcare industry: "We are thrilled by the broad response to Talking Medicines Drug-GPT and our strategic partnerships. This success underscores our dedication to empowering healthcare stakeholders with actionable insights derived from advanced data science and artificial intelligence."
Looking ahead, Talking Medicines remains committed to driving innovation and fostering collaborations that enhance healthcare decision-making through intelligence globally."
Https://talkingmedicines.com/2024/04/the-fusion-of-ai-and-strategy-a-look-through-drug-gpt/
Remember every time we get a tweet to say this has gone live, this is now producing data means its up to $5 a month income per sensor with little costs to generate that $5, should be in a position to move into Wyld very soon as CGT just been paid, fingers crossed its before the market catches on